To achieve proactive diabetes management in type 1 diabetes, accurate glucose prediction is critical. Due to complex glucose dynamics, diabetic glucose levels often exhibit highly nonlinear and nonstationary patterns, making accurate prediction challenging. Existing methods mainly focus on analyzing glucose levels in the time domain, failing to capture complex patterns. To address these gaps, a multi-scale time-frequency approach is proposed for accurate and personalized glucose prediction called MTGlu. A time-frequency decomposition-based module with optimized segmentation is proposed to uncover multi-scale nonstationary oscillation patterns. The temporal dependency learning module is further developed to capture nonlinear patterns at each scale. Moreover, we propose a new evaluation metric, abnormal time percentage, which accounts for the impact of abnormal glucose predictions on treatment. The proposed approach performs well on real patient data, achieving a 42% improvement in prediction performance on average compared to other methods.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

MTGlu: A Multi-scale Time-Frequency Approach for Personalized Glucose Prediction in Type 1 Diabetes

  • Lantian Fu,
  • Ying Li,
  • Xuxue Sun,
  • Zhenning Bao,
  • Yuxin Wen,
  • Yuanyuan Zhang

摘要

To achieve proactive diabetes management in type 1 diabetes, accurate glucose prediction is critical. Due to complex glucose dynamics, diabetic glucose levels often exhibit highly nonlinear and nonstationary patterns, making accurate prediction challenging. Existing methods mainly focus on analyzing glucose levels in the time domain, failing to capture complex patterns. To address these gaps, a multi-scale time-frequency approach is proposed for accurate and personalized glucose prediction called MTGlu. A time-frequency decomposition-based module with optimized segmentation is proposed to uncover multi-scale nonstationary oscillation patterns. The temporal dependency learning module is further developed to capture nonlinear patterns at each scale. Moreover, we propose a new evaluation metric, abnormal time percentage, which accounts for the impact of abnormal glucose predictions on treatment. The proposed approach performs well on real patient data, achieving a 42% improvement in prediction performance on average compared to other methods.